← Back to Clinical Trials
Recruiting NCT06901700

NCT06901700 Effects of Home-based Lower Extremity Muscle Power Training on Functional Muscle and Balance Performance in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06901700
Status Recruiting
Phase
Sponsor National Yang Ming Chiao Tung University
Condition Older Adults
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-07-16
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Experimental Groupcontrol group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-07-16 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: Muscle power, defined as the rate at which muscular force is generated to produce movement, declines more rapidly with age than muscle strength. The decline in lower extremity muscle power is associated with reduced functional independence, impaired mobility, and an increased risk of falls among older adults. While power training has been shown to improve muscle power, balance, and functional abilities, the feasibility and effectiveness of home-based interventions have not been thoroughly investigated. Purpose: The aim of this study is to investigate the effects of home-based lower extremity muscle power training program on functional muscle and balance performance in older adults. Methods: This is a single-blind, randomized controlled trial. Forty community-dwelling older adults will be recruited and randomly assigned to the experimental group (n=20) and control group (n=20). Participants in the experimental group will complete 24 sessions of home-based lower extremity muscle power training targeting the lower limb muscle groups in 8 weeks. The training intensity will be progressively adjusted according to participants' performance. Participants in the control group will maintain their daily activities. In addition, both groups will receive health education. Primary outcomes include functional muscle power measured by the Four-Step Stair Climb Power Test, functional muscle strength measured by Five Times Sit-to-Stand Test, and the functional balance performance measured by the Mini-BESTest, and Timed Up and Go Test. The fall confidence, as the secondary outcome, will be measured by Falls Efficacy Scale International. Statistical analysis: The SPSS® version 29 will be used for statistical analysis. Independent-t-test or chi-square test will be conducted to compare the baseline demographic characteristics between groups. Two-way repeated measure ANOVA will be used to compare the differences between groups and times, post-hoc analyses will be performed using Tukey's test. The significance level is set at 0.05.

Eligibility Criteria

Inclusion Criteria: * 65\~80 years old community-dwelling adults * MMSE≥24 * Use smart phone routinely Exclusion Criteria: * Recent (\<1 year) musculoskeletal injury or disability in the lower limbs * Unstable cardiovascular, neurological disease, or metabolic disease interfering with participating in the study

Contact & Investigator

Central Contact

Ray-Yau Wang, PhD

✉ rywang@nycu.edu.tw

📞 +88628267210

Principal Investigator

Ray-Yau Wang, PhD

PRINCIPAL INVESTIGATOR

National Yang Ming Chiao Tung University

Frequently Asked Questions

Who can join the NCT06901700 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 80 Years, studying Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06901700 currently recruiting?

Yes, NCT06901700 is actively recruiting participants. Contact the research team at rywang@nycu.edu.tw for enrollment information.

Where is the NCT06901700 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06901700 clinical trial?

NCT06901700 is sponsored by National Yang Ming Chiao Tung University. The principal investigator is Ray-Yau Wang, PhD at National Yang Ming Chiao Tung University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology